Novorex

Private

Seongnam-siHealthcare & Life Scienceshttps://novorex.com/

Last Round

Series B

Apr 9, 2026

Est. Valuation

$41.08M

Total Funding Raised

$33.45M

Company Overview

Novorex is a biotechnology company that develops small-molecule drugs for cancer and central nervous system diseases using an AI-driven, fragment-based drug discovery platform.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Warehouse Automation, Pharma Supply Chain, Supply Chain Tracking

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

pharmacy automationmedication dispensingpharmacy roboticsinventory management softwareautomated dispensing cabinetADCmedication managementpharmacy technologyhealthcare automationpharmacy inventory trackingmedication error reductionpharmacy workflowhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novorex Comps

Public and private peers based on sector, stage, and business model.

Novorex comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Novorex Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Apr 9, 2026
Series A Extension	Nov 21, 2023
Series A	Jul 1, 2021
Pre Seed	Feb 1, 2020

View all Funding Rounds

Novorex Investors

Notable investors and investment history

Novorex investors
Investor	Rounds
Hana Ventures	Series A Extension
KOTEC	Series A Extension
BNH INVESTMENT	Series A Extension
Hyundai Venture Investment Corporation	Series B
UTC Investment	Series B, Series A Extension
KB Investment	Series B, Series A Extension
Samsung Securities	Series B

View all Investors

Novorex Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Novorex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novorex's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeongnam-si

Employee Range3

Year Founded2020

Last FundingApr 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.